(Q84584419)
Statements
The impact of decreased bead count to determine concentrations of amyloid beta1-42, total-tau, and phosphorylated-tau181 in human cerebrospinal fluid using xMAP technology (English)
Olaf Bjornstal
Kathryn Rogers
Wei Zhang
Richard Delhaye
Michele Malone
Steve Unger
William Nowatzke